Semaglutide

Semaglutide is a GLP-1 receptor agonist commonly studied in metabolic and incretin research involving glucose regulation, insulin signalling, gastric-emptying pathways, appetite signalling and energy balance. Lianhua Peptide Co. — Hangzhou · Zhejiang · China — supplies Semaglutide for laboratory research with cGMP manufacturing standards, >98% purity specifications, HPLC-MS quality analysis, practical box ordering and tracked international fulfilment.

For laboratory and research use only. Not for human or animal consumption.